English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

1College of Health and Human Sciences, Charles Darwin University, Casuarina, Northern Territory 0909, Australia; 2University of Adelaide, Adelaide, South Australia 5005, Australia; 3School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India; 4Department of Biochemistry, Bharathiar University, Coimbatore, Tamil Nadu, India Dear editor Zhang and colleagues have conducted a network meta-analysis regarding fulvestrant combined targeted therapies for breast cancer, which has been published in the Cancer Management and Research journal. The study itself is interesting in its approach.

cancer management and research

&lt;p&gt;Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy&lt;/p&gt;